Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro mod...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996114001788 |
id |
doaj-a3e0fb76bd764bb882e1a79cace17569 |
---|---|
record_format |
Article |
spelling |
doaj-a3e0fb76bd764bb882e1a79cace175692021-03-22T12:41:34ZengElsevierNeurobiology of Disease1095-953X2014-10-0170214223Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's diseaseLaurie H. Sanders0Jennifer McCoy1Xiaoping Hu2Pier G. Mastroberardino3Bryan C. Dickinson4Christopher J. Chang5Charleen T. Chu6Bennett Van Houten7J.T. Greenamyre8Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USADepartment of Genetics, Erasmus MC, Rotterdam, The NetherlandsDepartment of Chemistry, University of California, Berkeley, CA 94720, USADepartment of Chemistry, University of California, Berkeley, CA 94720, USA; Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USADepartment of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USADepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; The University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA 15213, USAPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15260, USA; Corresponding author at: University of Pittsburgh, 3501 Fifth Avenue, Suite 7039, Pittsburgh, PA 15260, USA. Fax: +1 412 648 9766.DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro models of PD, using a newly adapted histochemical assay for abasic sites and a quantitative polymerase chain reaction (QPCR)-based assay. We identified the molecular identity of mtDNA damage to be apurinic/apyrimidinic (abasic) sites in substantia nigra dopamine neurons, but not in cortical neurons from postmortem PD specimens. To model the systemic mitochondrial impairment of PD, rats were exposed to the pesticide rotenone. After rotenone treatment that does not cause neurodegeneration, abasic sites were visualized in nigral neurons, but not in cortex. Using a QPCR-based assay, a single rotenone dose induced mtDNA damage in midbrain neurons, but not in cortical neurons; similar results were obtained in vitro in cultured neurons. Importantly, these results indicate that mtDNA damage is detectable prior to any signs of degeneration — and is produced selectively in midbrain neurons under conditions of mitochondrial impairment. The selective vulnerability of midbrain neurons to mtDNA damage was not due to differential effects of rotenone on complex I since rotenone suppressed respiration equally in midbrain and cortical neurons. However, in response to complex I inhibition, midbrain neurons produced more mitochondrial H2O2 than cortical neurons. We report selective mtDNA damage as a molecular marker of vulnerable nigral neurons in PD and suggest that this may result from intrinsic differences in how these neurons respond to complex I defects. Further, the persistence of abasic sites suggests an ineffective base excision repair response in PD.http://www.sciencedirect.com/science/article/pii/S0969996114001788Parkinson's diseaseMitochondrial DNA damageAbasic sites |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Laurie H. Sanders Jennifer McCoy Xiaoping Hu Pier G. Mastroberardino Bryan C. Dickinson Christopher J. Chang Charleen T. Chu Bennett Van Houten J.T. Greenamyre |
spellingShingle |
Laurie H. Sanders Jennifer McCoy Xiaoping Hu Pier G. Mastroberardino Bryan C. Dickinson Christopher J. Chang Charleen T. Chu Bennett Van Houten J.T. Greenamyre Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease Neurobiology of Disease Parkinson's disease Mitochondrial DNA damage Abasic sites |
author_facet |
Laurie H. Sanders Jennifer McCoy Xiaoping Hu Pier G. Mastroberardino Bryan C. Dickinson Christopher J. Chang Charleen T. Chu Bennett Van Houten J.T. Greenamyre |
author_sort |
Laurie H. Sanders |
title |
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease |
title_short |
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease |
title_full |
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease |
title_fullStr |
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease |
title_full_unstemmed |
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease |
title_sort |
mitochondrial dna damage: molecular marker of vulnerable nigral neurons in parkinson's disease |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
2014-10-01 |
description |
DNA damage can cause (and result from) oxidative stress and mitochondrial impairment, both of which are implicated in the pathogenesis of Parkinson's disease (PD). We therefore examined the role of mitochondrial DNA (mtDNA) damage in human postmortem brain tissue and in in vivo and in vitro models of PD, using a newly adapted histochemical assay for abasic sites and a quantitative polymerase chain reaction (QPCR)-based assay. We identified the molecular identity of mtDNA damage to be apurinic/apyrimidinic (abasic) sites in substantia nigra dopamine neurons, but not in cortical neurons from postmortem PD specimens. To model the systemic mitochondrial impairment of PD, rats were exposed to the pesticide rotenone. After rotenone treatment that does not cause neurodegeneration, abasic sites were visualized in nigral neurons, but not in cortex. Using a QPCR-based assay, a single rotenone dose induced mtDNA damage in midbrain neurons, but not in cortical neurons; similar results were obtained in vitro in cultured neurons. Importantly, these results indicate that mtDNA damage is detectable prior to any signs of degeneration — and is produced selectively in midbrain neurons under conditions of mitochondrial impairment. The selective vulnerability of midbrain neurons to mtDNA damage was not due to differential effects of rotenone on complex I since rotenone suppressed respiration equally in midbrain and cortical neurons. However, in response to complex I inhibition, midbrain neurons produced more mitochondrial H2O2 than cortical neurons. We report selective mtDNA damage as a molecular marker of vulnerable nigral neurons in PD and suggest that this may result from intrinsic differences in how these neurons respond to complex I defects. Further, the persistence of abasic sites suggests an ineffective base excision repair response in PD. |
topic |
Parkinson's disease Mitochondrial DNA damage Abasic sites |
url |
http://www.sciencedirect.com/science/article/pii/S0969996114001788 |
work_keys_str_mv |
AT lauriehsanders mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT jennifermccoy mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT xiaopinghu mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT piergmastroberardino mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT bryancdickinson mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT christopherjchang mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT charleentchu mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT bennettvanhouten mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease AT jtgreenamyre mitochondrialdnadamagemolecularmarkerofvulnerablenigralneuronsinparkinsonsdisease |
_version_ |
1724208267152850944 |